HomeAI · summaries
Storia in 2 fonti
United Therapeutics Corporation Announces FDA Filing Acceptance of New Drug Application for Ralinepag to Treat Pulmonary Arterial Hypertension
United Therapeutics Corporation Announces FDA Filing Acceptance of New Drug Application for Ralinepag to Treat Pulmonary Arterial Hypertension
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
United Therapeutics Corporation Announces FDA Filing Acceptance of New Drug Application for Ralinepag to Treat Pulmonary Arterial…
United Therapeutics Corporation Announces FDA Filing Acceptance of New Drug Application for Ralinepag to Treat Pulmonary Arterial Hypertension
- ·
healio.com
FDA accepts new drug application for ralinepag in PAH
The FDA accepted United Therapeutics’ new drug application for ralinepag, a once-daily oral prostacyclin, for the treatment of pulmonary arterial hypertension, according to a…